Company / Revenue per Share
Bristol Myers Squibb Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$23.19
FY2025
5-year range
$15.27 / $23.19
FY2021-FY2025
Trend
+3.0%
vs FY2024
Sector context
#24 of 154
Health Care
What the data says
Bristol Myers Squibb's revenue per share of $23.19 is higher than 84% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 4 consecutive years, from $15.27 in FY2021 to $23.19 in FY2025.
Based on SEC 10-K filings.
23.19 in FY2025 with a 5-year CAGR of -2.2%. Top quartile in the Health Care sector.
Improved from $20.66 to $23.19 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +7.2%
- 5-Year CAGR
- -2.2%
- 10-Year CAGR
- -
Sector benchmark
+53.7% above sector average
Key checks
Key Insights
- Bristol Myers Squibb's revenue per share has grown for 4 consecutive years.
- In FY2025, revenue per share increased 3.0% year-over-year.
- Ranks #24 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2020.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.19 | +3.0% |
| FY2024 | $22.51 | +8.9% |
| FY2023 | $20.66 | +9.7% |
| FY2022 | $18.83 | +23.3% |
| FY2021 | $15.27 | -41.2% |
| FY2020 | $25.97 | +106.5% |
| FY2019 | $12.58 | +8.8% |
| FY2018 | $11.56 | -6.5% |
| FY2017 | $12.37 | +30.1% |
| FY2016 | $9.51 | -3.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026